OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Clinical Immunology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Full consideration of the pollen exposure effect in clinical trial design for pollen-induced allergic rhinitis	114
Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?	84
Pepsin, trypsin, and MUC5B are independent risk factors for hearing impairment in patients with laryngopharyngeal reflux-related chronic secretory otitis media	67
The therapeutic effect of mRNA vaccines in glioma: a comprehensive review	64
Aleukemic variant of T-cell large granular lymphocyte leukemia in patients with rheumatoid arthritis - diagnostically challenging subtype	58
Bimekizumab for the treatment of psoriatic arthritis	55
Immunobiology and treatment of cutaneous T-cell lymphoma	55
How could our genetics impact COVID-19 vaccine response?	42
Pan-cancer analysis of the prognostic significance of ACKR2 expression and the related genetic/epigenetic dysregulations	40
Pioglitazone as a potential modulator in autoimmune diseases: a review on its effects in systemic lupus erythematosus, psoriasis, inflammatory bowel disease, and multiple sclerosis	39
CAR-T cell immunotherapy of malignant melanoma	33
A prospective single-arm study on the efficacy and safety of short-course oral corticosteroids followed by topical corticosteroids in patients with severe chronic rhinosinusitis with nasal polyps	32
The multidisciplinary approach to diagnosing inborn errors of immunity: a comprehensive review of discipline-based manifestations	31
A critical review of dupilumab for adult patients with prurigo nodularis	31
Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives	30
Bradford Hill and breast implant illness: no evidence for causal association with breast implants	30
The effect of intense pulsed light combined with topical 0.05% Cyclosporin A eyedrops in the treatment of Sjögren’s syndrome related dry eye	29
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease	29
IRF1 expression might be a biomarker of CD8+ T cell infiltration in cutaneous melanoma	28
Food immunotherapy: current status and future needs	27
More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment	27
Pathogen-specific cell-mediated immunity to guide the management of cytomegalovirus in solid organ transplantation: state of the art clinical review	27
Biomarkers guiding biological therapeutic strategies in chronic rhinosinusitis with nasal polyps: an emerging challenge	27
Re-evaluation of nailfold capillaroscopy in discriminating primary from secondary Raynaud’s phenomenon and in predicting systemic sclerosis: a randomised observational prospective cohort study	27
Differential risk of autoimmune disorders in non-traumatic osteonecrosis: clue to pathogenesis	26

Drug development in systemic sclerosis: novel therapeutics to watch